| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2014 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 18 | Q2 2024 | 5.1% |
| SAGE THERAPEUTICS INC | 17 | Q1 2024 | 5.0% |
| BLUEPRINT MEDICINES CORP | 16 | Q2 2024 | 3.5% |
| ELEVANCE HEALTH INC | 15 | Q2 2024 | 6.7% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| REVVITY INC | 14 | Q1 2024 | 4.2% |
| RELAY THERAPEUTICS INC | 14 | Q2 2024 | 2.6% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| LONGBOARD PHARMACEUTICALS IN | 14 | Q2 2024 | 2.8% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.